Skip to content

Tracking anti-microbial resistance across care settings in Liverpool (TRACS- Liverpool) - Part 1

Tracking anti-microbial resistance across care settings in Liverpool (TRACS-Liverpool) Part 1: informing the design and development of an observational cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN11601053
Enrollment
45
Registered
2021-12-17
Start date
2022-02-01
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection control Infections and Infestations

Interventions

Following enrolment participants will undertake a single semi-structured interview with the research team. This may be online or face-to-face. This will complete their involvement in the study.

Sponsors

Liverpool School of Tropical Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female aged 18 years or above 2. Health professionals working in institutions that operate in Merseyside 3. Having knowledge and/or experience to share on the research questions 4. Able to facilitate access to relevant data required in the study 5. Willing and able to give informed consent for participation in the study

Exclusion criteria

Exclusion criteria: 1. Not willing or available to participate in the study

Design outcomes

Primary

MeasureTime frame
1.1. Estimate rates of ESBL-E/CPE acquisition and infection in two Liverpool acute hospitals, using readily available routine data sources at a single time point Measured using interviews at a single time point: 2.1. Scope and document relevant routine and secondary data sources on local ESBL-E/CPE transmission. 2.2. Document key informants’ perspectives on the acceptability of the Part 2 study and how to improve it. 2.3. Map facility infrastructure, describe patient journeys within and between care facilities, and suggest how these might affect ESBL-E/CPE acquisition and prevention. 2.4. Review and summarise infection control policies for ESBL and CPE and suggest how these might be linked to protection from or acquisition of ESBL/CPE

Secondary

MeasureTime frame
There are no secondary outcome measures

Countries

England, United Kingdom

Contacts

Public ContactMaria Moore
maria.moore@lstmed.ac.uk+44 151 705 2566

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026